WO2023128884A1 - Thermoreversible gel formulation with herbal active materials in order to calm and accelarate the healing of burnt skin - Google Patents
Thermoreversible gel formulation with herbal active materials in order to calm and accelarate the healing of burnt skin Download PDFInfo
- Publication number
- WO2023128884A1 WO2023128884A1 PCT/TR2021/051539 TR2021051539W WO2023128884A1 WO 2023128884 A1 WO2023128884 A1 WO 2023128884A1 TR 2021051539 W TR2021051539 W TR 2021051539W WO 2023128884 A1 WO2023128884 A1 WO 2023128884A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- gel formulation
- healing
- calm
- skin
- extract
- Prior art date
Links
- 238000009472 formulation Methods 0.000 title claims abstract description 23
- 239000000203 mixture Substances 0.000 title claims abstract description 23
- 230000035876 healing Effects 0.000 title claims abstract description 14
- 239000011149 active material Substances 0.000 title description 3
- 235000007303 Thymus vulgaris Nutrition 0.000 claims description 5
- 229920000642 polymer Polymers 0.000 claims description 5
- 239000001585 thymus vulgaris Substances 0.000 claims description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 5
- 235000020759 St. John’s wort extract Nutrition 0.000 claims description 4
- 239000000284 extract Substances 0.000 claims description 4
- 229940114496 olive leaf extract Drugs 0.000 claims description 4
- 238000005507 spraying Methods 0.000 claims description 4
- 229940099416 st. john's wort extract Drugs 0.000 claims description 4
- 239000008367 deionised water Substances 0.000 claims description 3
- 229910021641 deionized water Inorganic materials 0.000 claims description 3
- 239000000546 pharmaceutical excipient Substances 0.000 claims description 2
- 241000246358 Thymus Species 0.000 claims 3
- RVGRUAULSDPKGF-UHFFFAOYSA-N Poloxamer Chemical compound C1CO1.CC1CO1 RVGRUAULSDPKGF-UHFFFAOYSA-N 0.000 claims 2
- 229920001992 poloxamer 407 Polymers 0.000 claims 2
- 229940044476 poloxamer 407 Drugs 0.000 claims 2
- 229940093430 polyethylene glycol 1500 Drugs 0.000 claims 2
- 239000003755 preservative agent Substances 0.000 claims 2
- 230000002335 preservative effect Effects 0.000 claims 2
- 238000000034 method Methods 0.000 abstract description 8
- 238000004519 manufacturing process Methods 0.000 abstract description 7
- 239000000499 gel Substances 0.000 description 19
- 239000000047 product Substances 0.000 description 8
- 210000001519 tissue Anatomy 0.000 description 7
- 239000007921 spray Substances 0.000 description 6
- 244000141009 Hypericum perforatum Species 0.000 description 5
- 206010052428 Wound Diseases 0.000 description 5
- 208000027418 Wounds and injury Diseases 0.000 description 5
- 239000006071 cream Substances 0.000 description 5
- 239000003921 oil Substances 0.000 description 5
- 235000019198 oils Nutrition 0.000 description 5
- 239000002674 ointment Substances 0.000 description 5
- 238000011282 treatment Methods 0.000 description 5
- 241000196324 Embryophyta Species 0.000 description 4
- 235000017309 Hypericum perforatum Nutrition 0.000 description 4
- 206010002091 Anaesthesia Diseases 0.000 description 3
- 240000007817 Olea europaea Species 0.000 description 3
- 239000000443 aerosol Substances 0.000 description 3
- 230000037005 anaesthesia Effects 0.000 description 3
- 230000002421 anti-septic effect Effects 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 208000014674 injury Diseases 0.000 description 3
- 230000003020 moisturizing effect Effects 0.000 description 3
- 230000036407 pain Effects 0.000 description 3
- 230000035945 sensitivity Effects 0.000 description 3
- 230000008733 trauma Effects 0.000 description 3
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical compound C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 description 2
- REPVLJRCJUVQFA-UHFFFAOYSA-N (-)-isopinocampheol Natural products C1C(O)C(C)C2C(C)(C)C1C2 REPVLJRCJUVQFA-UHFFFAOYSA-N 0.000 description 2
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- YCCILVSKPBXVIP-UHFFFAOYSA-N 2-(4-hydroxyphenyl)ethanol Chemical compound OCCC1=CC=C(O)C=C1 YCCILVSKPBXVIP-UHFFFAOYSA-N 0.000 description 2
- 206010006802 Burns second degree Diseases 0.000 description 2
- 206010006803 Burns third degree Diseases 0.000 description 2
- 102000002322 Egg Proteins Human genes 0.000 description 2
- 108010000912 Egg Proteins Proteins 0.000 description 2
- WEEGYLXZBRQIMU-UHFFFAOYSA-N Eucalyptol Chemical compound C1CC2CCC1(C)OC2(C)C WEEGYLXZBRQIMU-UHFFFAOYSA-N 0.000 description 2
- 235000002725 Olea europaea Nutrition 0.000 description 2
- VYGQUTWHTHXGQB-FFHKNEKCSA-N Retinol Palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C VYGQUTWHTHXGQB-FFHKNEKCSA-N 0.000 description 2
- 206010042496 Sunburn Diseases 0.000 description 2
- 240000002657 Thymus vulgaris Species 0.000 description 2
- 239000003242 anti bacterial agent Substances 0.000 description 2
- 230000000845 anti-microbial effect Effects 0.000 description 2
- UAHWPYUMFXYFJY-UHFFFAOYSA-N beta-myrcene Chemical compound CC(C)=CCCC(=C)C=C UAHWPYUMFXYFJY-UHFFFAOYSA-N 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 230000036760 body temperature Effects 0.000 description 2
- CKDOCTFBFTVPSN-UHFFFAOYSA-N borneol Natural products C1CC2(C)C(C)CC1C2(C)C CKDOCTFBFTVPSN-UHFFFAOYSA-N 0.000 description 2
- 229940116229 borneol Drugs 0.000 description 2
- 230000001914 calming effect Effects 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- DTGKSKDOIYIVQL-UHFFFAOYSA-N dl-isoborneol Natural products C1CC2(C)C(O)CC1C2(C)C DTGKSKDOIYIVQL-UHFFFAOYSA-N 0.000 description 2
- VYFYYTLLBUKUHU-UHFFFAOYSA-N dopamine Chemical compound NCCC1=CC=C(O)C(O)=C1 VYFYYTLLBUKUHU-UHFFFAOYSA-N 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- IYRMWMYZSQPJKC-UHFFFAOYSA-N kaempferol Chemical compound C1=CC(O)=CC=C1C1=C(O)C(=O)C2=C(O)C=C(O)C=C2O1 IYRMWMYZSQPJKC-UHFFFAOYSA-N 0.000 description 2
- MWDZOUNAPSSOEL-UHFFFAOYSA-N kaempferol Natural products OC1=C(C(=O)c2cc(O)cc(O)c2O1)c3ccc(O)cc3 MWDZOUNAPSSOEL-UHFFFAOYSA-N 0.000 description 2
- CDOSHBSSFJOMGT-UHFFFAOYSA-N linalool Chemical compound CC(C)=CCCC(C)(O)C=C CDOSHBSSFJOMGT-UHFFFAOYSA-N 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 239000004006 olive oil Substances 0.000 description 2
- 235000008390 olive oil Nutrition 0.000 description 2
- HFPZCAJZSCWRBC-UHFFFAOYSA-N p-cymene Chemical compound CC(C)C1=CC=C(C)C=C1 HFPZCAJZSCWRBC-UHFFFAOYSA-N 0.000 description 2
- 238000004806 packaging method and process Methods 0.000 description 2
- 239000003380 propellant Substances 0.000 description 2
- 231100000241 scar Toxicity 0.000 description 2
- QZAYGJVTTNCVMB-UHFFFAOYSA-N serotonin Chemical compound C1=C(O)C=C2C(CCN)=CNC2=C1 QZAYGJVTTNCVMB-UHFFFAOYSA-N 0.000 description 2
- 241000894007 species Species 0.000 description 2
- 230000001954 sterilising effect Effects 0.000 description 2
- 238000004659 sterilization and disinfection Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- MGSRCZKZVOBKFT-UHFFFAOYSA-N thymol Chemical compound CC(C)C1=CC=C(C)C=C1O MGSRCZKZVOBKFT-UHFFFAOYSA-N 0.000 description 2
- QAIPRVGONGVQAS-DUXPYHPUSA-N trans-caffeic acid Chemical compound OC(=O)\C=C\C1=CC=C(O)C(O)=C1 QAIPRVGONGVQAS-DUXPYHPUSA-N 0.000 description 2
- 230000017260 vegetative to reproductive phase transition of meristem Effects 0.000 description 2
- GRWFGVWFFZKLTI-IUCAKERBSA-N (-)-α-pinene Chemical compound CC1=CC[C@@H]2C(C)(C)[C@H]1C2 GRWFGVWFFZKLTI-IUCAKERBSA-N 0.000 description 1
- 239000001490 (3R)-3,7-dimethylocta-1,6-dien-3-ol Substances 0.000 description 1
- PNMNSRMFRJNZFD-IPEIANHJSA-N (4S,5E,6S)-4-(carboxymethyl)-5-ethylidene-6-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-4H-pyran-3-carboxylic acid Chemical compound C\C=C1\[C@H](O[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)OC=C([C@H]1CC(O)=O)C(O)=O PNMNSRMFRJNZFD-IPEIANHJSA-N 0.000 description 1
- GMQXOLRKJQWPNB-UHFFFAOYSA-N (8E)-ligstroside Natural products CC=C1C(CC(=O)OCCC=2C=CC(O)=CC=2)C(C(=O)OC)=COC1OC1OC(CO)C(O)C(O)C1O GMQXOLRKJQWPNB-UHFFFAOYSA-N 0.000 description 1
- ACEAELOMUCBPJP-UHFFFAOYSA-N (E)-3,4,5-trihydroxycinnamic acid Natural products OC(=O)C=CC1=CC(O)=C(O)C(O)=C1 ACEAELOMUCBPJP-UHFFFAOYSA-N 0.000 description 1
- DSSYKIVIOFKYAU-XCBNKYQSSA-N (R)-camphor Chemical compound C1C[C@@]2(C)C(=O)C[C@@H]1C2(C)C DSSYKIVIOFKYAU-XCBNKYQSSA-N 0.000 description 1
- CDOSHBSSFJOMGT-JTQLQIEISA-N (R)-linalool Natural products CC(C)=CCC[C@@](C)(O)C=C CDOSHBSSFJOMGT-JTQLQIEISA-N 0.000 description 1
- XSCVKBFEPYGZSL-UHFFFAOYSA-N 11-methyloleoside Natural products CC=C1C(CC(O)=O)C(C(=O)OC)=COC1OC1C(O)C(O)C(O)C(CO)O1 XSCVKBFEPYGZSL-UHFFFAOYSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- SCZVLDHREVKTSH-UHFFFAOYSA-N 4',5,7-trihydroxy-3'-methoxyflavone Chemical compound C1=C(O)C(OC)=CC(C=2OC3=CC(O)=CC(O)=C3C(=O)C=2)=C1 SCZVLDHREVKTSH-UHFFFAOYSA-N 0.000 description 1
- RFWGABANNQMHMZ-UHFFFAOYSA-N 8-acetoxy-7-acetyl-6,7,7a,8-tetrahydro-5H-benzo[g][1,3]dioxolo[4',5':4,5]benzo[1,2,3-de]quinoline Natural products CC=C1C(CC(=O)OCCC=2C=C(O)C(O)=CC=2)C(C(=O)OC)=COC1OC1OC(CO)C(O)C(O)C1O RFWGABANNQMHMZ-UHFFFAOYSA-N 0.000 description 1
- 241000130784 Arnebia euchroma Species 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 206010006797 Burns first degree Diseases 0.000 description 1
- 235000003255 Carthamus tinctorius Nutrition 0.000 description 1
- 244000020518 Carthamus tinctorius Species 0.000 description 1
- 240000005250 Chrysanthemum indicum Species 0.000 description 1
- 235000018959 Chrysanthemum indicum Nutrition 0.000 description 1
- 208000032544 Cicatrix Diseases 0.000 description 1
- 241000723346 Cinnamomum camphora Species 0.000 description 1
- UBSCDKPKWHYZNX-UHFFFAOYSA-N Demethoxycapillarisin Natural products C1=CC(O)=CC=C1OC1=CC(=O)C2=C(O)C=C(O)C=C2O1 UBSCDKPKWHYZNX-UHFFFAOYSA-N 0.000 description 1
- HKVGJQVJNQRJPO-UHFFFAOYSA-N Demethyloleuropein Natural products O1C=C(C(O)=O)C(CC(=O)OCCC=2C=C(O)C(O)=CC=2)C(=CC)C1OC1OC(CO)C(O)C(O)C1O HKVGJQVJNQRJPO-UHFFFAOYSA-N 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 239000001293 FEMA 3089 Substances 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 206010020649 Hyperkeratosis Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- DBLDQZASZZMNSL-QMMMGPOBSA-N L-tyrosinol Natural products OC[C@@H](N)CC1=CC=C(O)C=C1 DBLDQZASZZMNSL-QMMMGPOBSA-N 0.000 description 1
- 241000207923 Lamiaceae Species 0.000 description 1
- GMQXOLRKJQWPNB-JSTGBQKGSA-N Ligstroside Natural products COC(=O)C1=CO[C@@H](O[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)C(=CC)[C@@H]1CC(=O)OCCc3ccc(O)cc3 GMQXOLRKJQWPNB-JSTGBQKGSA-N 0.000 description 1
- 235000006679 Mentha X verticillata Nutrition 0.000 description 1
- 235000002899 Mentha suaveolens Nutrition 0.000 description 1
- 235000004357 Mentha x piperita Nutrition 0.000 description 1
- 241001479543 Mentha x piperita Species 0.000 description 1
- 235000001636 Mentha x rotundifolia Nutrition 0.000 description 1
- 239000004909 Moisturizer Substances 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 241000795633 Olea <sea slug> Species 0.000 description 1
- 241000207834 Oleaceae Species 0.000 description 1
- PNMNSRMFRJNZFD-OILIDSPUSA-N Oleoside Natural products O=C(O)C[C@H]1/C(=C/C)/[C@H](O[C@H]2[C@@H](O)[C@H](O)[C@H](O)[C@H](CO)O2)OC=C1C(=O)O PNMNSRMFRJNZFD-OILIDSPUSA-N 0.000 description 1
- RFWGABANNQMHMZ-HYYSZPHDSA-N Oleuropein Chemical compound O([C@@H]1OC=C([C@H](C1=CC)CC(=O)OCCC=1C=C(O)C(O)=CC=1)C(=O)OC)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O RFWGABANNQMHMZ-HYYSZPHDSA-N 0.000 description 1
- 235000003181 Panax pseudoginseng Nutrition 0.000 description 1
- 244000131316 Panax pseudoginseng Species 0.000 description 1
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 1
- 244000173853 Sanguisorba officinalis Species 0.000 description 1
- 235000008282 Sanguisorba officinalis Nutrition 0.000 description 1
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 1
- 239000005844 Thymol Substances 0.000 description 1
- 241000209140 Triticum Species 0.000 description 1
- 235000021307 Triticum Nutrition 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 239000012190 activator Substances 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- VYBREYKSZAROCT-UHFFFAOYSA-N alpha-myrcene Natural products CC(=C)CCCC(=C)C=C VYBREYKSZAROCT-UHFFFAOYSA-N 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- 230000002924 anti-infective effect Effects 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- KZNIFHPLKGYRTM-UHFFFAOYSA-N apigenin Chemical compound C1=CC(O)=CC=C1C1=CC(=O)C2=C(O)C=C(O)C=C2O1 KZNIFHPLKGYRTM-UHFFFAOYSA-N 0.000 description 1
- XADJWCRESPGUTB-UHFFFAOYSA-N apigenin Natural products C1=CC(O)=CC=C1C1=CC(=O)C2=CC(O)=C(O)C=C2O1 XADJWCRESPGUTB-UHFFFAOYSA-N 0.000 description 1
- 235000008714 apigenin Nutrition 0.000 description 1
- 229940117893 apigenin Drugs 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 229910021538 borax Inorganic materials 0.000 description 1
- 229940074360 caffeic acid Drugs 0.000 description 1
- 235000004883 caffeic acid Nutrition 0.000 description 1
- 229930008380 camphor Natural products 0.000 description 1
- 229960000846 camphor Drugs 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- HHTWOMMSBMNRKP-UHFFFAOYSA-N carvacrol Natural products CC(=C)C1=CC=C(C)C(O)=C1 HHTWOMMSBMNRKP-UHFFFAOYSA-N 0.000 description 1
- RECUKUPTGUEGMW-UHFFFAOYSA-N carvacrol Chemical compound CC(C)C1=CC=C(C)C(O)=C1 RECUKUPTGUEGMW-UHFFFAOYSA-N 0.000 description 1
- 235000007746 carvacrol Nutrition 0.000 description 1
- 235000019438 castor oil Nutrition 0.000 description 1
- 239000004359 castor oil Substances 0.000 description 1
- 238000012512 characterization method Methods 0.000 description 1
- UOSZQIQUCYTISS-UHFFFAOYSA-N chrysoeriol Natural products C1=C(O)C(C)=CC(C=2OC3=CC(O)=CC(O)=C3C(=O)C=2)=C1 UOSZQIQUCYTISS-UHFFFAOYSA-N 0.000 description 1
- QAIPRVGONGVQAS-UHFFFAOYSA-N cis-caffeic acid Natural products OC(=O)C=CC1=CC=C(O)C(O)=C1 QAIPRVGONGVQAS-UHFFFAOYSA-N 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 238000001804 debridement Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 229960003638 dopamine Drugs 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 210000002969 egg yolk Anatomy 0.000 description 1
- 235000013345 egg yolk Nutrition 0.000 description 1
- 235000013601 eggs Nutrition 0.000 description 1
- 230000005611 electricity Effects 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 235000021323 fish oil Nutrition 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 239000003193 general anesthetic agent Substances 0.000 description 1
- 230000002070 germicidal effect Effects 0.000 description 1
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 1
- 210000004209 hair Anatomy 0.000 description 1
- 239000012676 herbal extract Substances 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- IWBJJCOKGLUQIZ-HQKKAZOISA-N hyperforin Chemical compound OC1=C(CC=C(C)C)C(=O)[C@@]2(CC=C(C)C)C[C@H](CC=C(C)C)[C@](CCC=C(C)C)(C)[C@]1(C(=O)C(C)C)C2=O IWBJJCOKGLUQIZ-HQKKAZOISA-N 0.000 description 1
- QOVWXXKVLJOKNW-UHFFFAOYSA-N hyperforin Natural products CC(C)C(=O)C12CC(CC=C(C)C)(CC(CC=C(C)C)C1CCC=C(C)C)C(=C(CC=C(C)C)C2=O)O QOVWXXKVLJOKNW-UHFFFAOYSA-N 0.000 description 1
- BTXNYTINYBABQR-UHFFFAOYSA-N hypericin Chemical compound C12=C(O)C=C(O)C(C(C=3C(O)=CC(C)=C4C=33)=O)=C2C3=C2C3=C4C(C)=CC(O)=C3C(=O)C3=C(O)C=C(O)C1=C32 BTXNYTINYBABQR-UHFFFAOYSA-N 0.000 description 1
- 229940005608 hypericin Drugs 0.000 description 1
- PHOKTTKFQUYZPI-UHFFFAOYSA-N hypericin Natural products Cc1cc(O)c2c3C(=O)C(=Cc4c(O)c5c(O)cc(O)c6c7C(=O)C(=Cc8c(C)c1c2c(c78)c(c34)c56)O)O PHOKTTKFQUYZPI-UHFFFAOYSA-N 0.000 description 1
- 206010020718 hyperplasia Diseases 0.000 description 1
- 238000009776 industrial production Methods 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- WYXXLXHHWYNKJF-UHFFFAOYSA-N isocarvacrol Natural products CC(C)C1=CC=C(O)C(C)=C1 WYXXLXHHWYNKJF-UHFFFAOYSA-N 0.000 description 1
- 235000008777 kaempferol Nutrition 0.000 description 1
- GMQXOLRKJQWPNB-MVVLSVRYSA-N ligstroside Chemical compound O([C@@H]\1OC=C([C@H](C/1=C\C)CC(=O)OCCC=1C=CC(O)=CC=1)C(=O)OC)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O GMQXOLRKJQWPNB-MVVLSVRYSA-N 0.000 description 1
- 229930007744 linalool Natural products 0.000 description 1
- LRDGATPGVJTWLJ-UHFFFAOYSA-N luteolin Natural products OC1=CC(O)=CC(C=2OC3=CC(O)=CC(O)=C3C(=O)C=2)=C1 LRDGATPGVJTWLJ-UHFFFAOYSA-N 0.000 description 1
- 235000009498 luteolin Nutrition 0.000 description 1
- IQPNAANSBPBGFQ-UHFFFAOYSA-N luteolin Chemical compound C=1C(O)=CC(O)=C(C(C=2)=O)C=1OC=2C1=CC=C(O)C(O)=C1 IQPNAANSBPBGFQ-UHFFFAOYSA-N 0.000 description 1
- 239000001771 mentha piperita Substances 0.000 description 1
- 230000001333 moisturizer Effects 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- UXOUKMQIEVGVLY-UHFFFAOYSA-N morin Natural products OC1=CC(O)=CC(C2=C(C(=O)C3=C(O)C=C(O)C=C3O2)O)=C1 UXOUKMQIEVGVLY-UHFFFAOYSA-N 0.000 description 1
- 230000001338 necrotic effect Effects 0.000 description 1
- KYVUMEGNMQDSHO-UHFFFAOYSA-N oleoside dimethyl ester Natural products O1C=C(C(=O)OC)C(CC(=O)OC)C(=CC)C1OC1C(O)C(O)C(O)C(CO)O1 KYVUMEGNMQDSHO-UHFFFAOYSA-N 0.000 description 1
- 235000011576 oleuropein Nutrition 0.000 description 1
- RFWGABANNQMHMZ-CARRXEGNSA-N oleuropein Natural products COC(=O)C1=CO[C@@H](O[C@H]2O[C@@H](CO)[C@H](O)[C@@H](O)[C@@H]2O)C(=CC)[C@H]1CC(=O)OCCc3ccc(O)c(O)c3 RFWGABANNQMHMZ-CARRXEGNSA-N 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 210000004681 ovum Anatomy 0.000 description 1
- 239000008194 pharmaceutical composition Substances 0.000 description 1
- 150000002989 phenols Chemical class 0.000 description 1
- 239000000419 plant extract Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- SSKVDVBQSWQEGJ-UHFFFAOYSA-N pseudohypericin Natural products C12=C(O)C=C(O)C(C(C=3C(O)=CC(O)=C4C=33)=O)=C2C3=C2C3=C4C(C)=CC(O)=C3C(=O)C3=C(O)C=C(O)C1=C32 SSKVDVBQSWQEGJ-UHFFFAOYSA-N 0.000 description 1
- -1 q- cimene Chemical compound 0.000 description 1
- 238000003908 quality control method Methods 0.000 description 1
- 238000001959 radiotherapy Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 229940108325 retinyl palmitate Drugs 0.000 description 1
- 235000019172 retinyl palmitate Nutrition 0.000 description 1
- 239000011769 retinyl palmitate Substances 0.000 description 1
- 230000037390 scarring Effects 0.000 description 1
- 230000037387 scars Effects 0.000 description 1
- 229940076279 serotonin Drugs 0.000 description 1
- 229910052709 silver Inorganic materials 0.000 description 1
- 239000004332 silver Substances 0.000 description 1
- 239000004328 sodium tetraborate Substances 0.000 description 1
- 235000010339 sodium tetraborate Nutrition 0.000 description 1
- 238000003892 spreading Methods 0.000 description 1
- 229960000790 thymol Drugs 0.000 description 1
- 235000004330 tyrosol Nutrition 0.000 description 1
- 229940099259 vaseline Drugs 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 230000029663 wound healing Effects 0.000 description 1
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/38—Clusiaceae, Hypericaceae or Guttiferae (Hypericum or Mangosteen family), e.g. common St. Johnswort
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/63—Oleaceae (Olive family), e.g. jasmine, lilac or ash tree
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/46—Ingredients of undetermined constitution or reaction products thereof, e.g. skin, bone, milk, cotton fibre, eggshell, oxgall or plant extracts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7015—Drug-containing film-forming compositions, e.g. spray-on
Definitions
- Thermoreversible gel formulation with herbal active materials in order to calm and accelarate the healing of burnt skin
- the present invention relates to thermoreversible gel formulation with herbal active materials to calm and accelerate the healing of burnt skin and production method.
- Burns are graded according to the severity of the traumas in the relevant technical field.
- first-degree burn said burn is soothed by applying a product to the skin according to the aforementioned grading.
- it is difficult to apply the same by contact since the skin sensitivity increases in second and third degree burns.
- Moisturizing creams, ointments and gels are applied for sunburns and first degree burns.
- Anesthetic agents, silver-containing creams, antimicrobial ointments and antiseptic effective solutions are used in second-degree burns and traumas. Applications are made to calm the region since the upper layer of the skin is burned. The burn area is deep and wide in griping and severely traumatized third-degree burns. Tissue loss is high and the risk of infection is high. The wounds of these patients are dressed under anesthesia. Debridement treatments are applied in order to accelerate tissue healing. Antiseptic solutions, dressings and antimicrobial ointments are applied. Necrotic tissues are cleaned and blood circulation of the tissues is supported. In particular, burns and dryness of the skin are experienced in cancer patients who have undergone radiation therapy. This region requires moistening and calming.
- TR2017/22907 application numbered patent application In the treatment of wounds caused by the burn, in the elimination of previously burned scars, and also to help remove calluses found in the body, a drug that acts as an antibiotic, contains the extract of the mentha piperita (mint) plant with antiseptic properties, arnebia Vietnameseroma plant extract, turpentine oil, egg yolk, castor oil and wax.
- mint mentha piperita
- TR2021/009075 relates to an ointment developed to provide treatment for two, three and four degree burns and to speed up the healing process.
- the ointment in question contains fish oil and Vaseline.
- TR2019/03364 application numbered patent application for use against heat, electricity, chemicals and/or flame-induced skin destruction, it relates to a topically viable pharmaceutical composition containing olive oil (olea europa fruit oil and /or olive oil), egg oil (ovum oil), wheat oil (triticium vulgrai oil), retinyl palmitate (vitamin A), alpha tocoferol (vitamin E).
- olive oil olea europa fruit oil and /or olive oil
- egg oil ovum oil
- wheat oil triticium vulgrai oil
- vitamin A retinyl palmitate
- vitamin E alpha tocoferol
- a product that consists of natural ingredients, used to have smooth skin that eliminates all kinds of burns on the skin and completely eliminates the pain and aesthetic problems caused by the burn is disclosed in the patent application with application number TR 2017/00569.
- the Chinese patent application with publication number CN103610869 A relates to a burn cream containing safflower, sanguisorba officinalis, cacumen biotae, pseudoginseng, resina draconis and chrysanthemum indicum.
- the current invention relates to the herbal and thermoreversible gel formulation (thermojel) and the production method of the gel formulation in question, which meets the aforementioned requirements, eliminates all disadvantages and brings some additional advantages, allows the burned skin to calm down and accelerates its healing.
- the invention is inspired by current situations and aims to solve the above-mentioned negativity.
- the main aim of the invention is; to obtain a gel formulation that provides innovation to the technical field with the application of both herbal and thermoreversible gels.
- herbal extracts that provide calming and accelerate healing in accordance with the sensitivity of the burn area are used.
- one of the important characterizing aspects of the invention is sprayable liquid gels, gelling with body temperature without any additional contact and application to the burnt area. Sprayed and squeezed, the final product acts as a support for moisturizing, soothing and healing of the skin by clinging to living surfaces by gelling with body temperature.
- the invention concerns the herbal and thermoreversible gel formulation (thermojel) that calms the burnt skin and accelerates its healing, and the production method of the gel formulation in question.
- the gel formulation in question basically, contains herbal content, polymer and excipients.
- the components contained in the gel formulation in question and the preferred and available percentage usage rates of these components are given in the table below.
- St. John's Wort extract is obtained from the whole or cut, dried flowering tops of Hypericum perforatum L. harvested during the flowering period.
- St. John's Wort known botanically as Hypericum perforatum, is a spreading, leafy herb that grows in open, disturbed areas in most of the world's temperate regions. The use of this species as a herbal medicine to treat various internal and external ailments dates back to the time of the ancient Greeks.
- H. perforatum consists of freely branching bush plants, typically 40 to 80 cm in height. Stems and branches are intensively covered with rectangular, smooth-edged leaves 1 to 3 cm long and 0.3 to 1.0 cm wide. It contains hypericin and hyperforin. It is used externally in the healing of wounds and burns. They cause changes in dopamine and serotonin levels in the body when taken internally.
- Olive leaf extract is obtained from Olea europaea, a plant belonging to the Oleaceae family.
- the olive tree is an evergreen tree that grows to a height of about 6 - 9 meters. It is endemic to the entire Mediterranean region, up to Southern European countries and Iran and beyond the Caucasus. Leaves are 7.5 cm long, opposite narrow, in the form of lance or linear, entire margins are pointed, silvery-green (graygreen) above, lighter underside, has fine white, flake-like hairs. Leaves can be collected throughout the year.
- the main components of olive leaves are oleuropein, ligstroside, I methyloleuropein and oleoside, and flavonoids (apigenin, kaempferol, luteolin, chrysoeriol) and phenolic compounds (caffeic acid, tyrosol, hydroxytrozole). In addition to antioxidant activity, it shows antiviral effect. It increases blood circulation.
- Thymus vulgaris that belongs to the Lamiaceae family. It is native to the Mediterranean. It grows up to 15 - 30 cm high and 40 cm wide. It is a bushy, evergreen shrub-type plant with purple or pink flowers and highly aromatic gray-green leaves. While it contains high levels of thymol, p-cymene and y-terpinene, it also contains carvacrol, borneol, 1 ,8-cineole, q- cimene, linalool, a-pinene, camphor and myrcene. It has a protective and germicidal effect against bacteria and fungi.
- the polymer is soluble in deionized water at +4 t C.
- the temperature of the water can be brought to +4 ‘C by cooling the water that is making the speed in the boiler walls industrially.
- the alternative way is to heat it.
- working in the cold positively affects stability, as the substances that will provide treatment support to the content will be disturbed by temperature.
- Another way is to break down the polymers with the help of powerful homogenizers. In the process, pilot trials continue through which method is more suitable for industrial production. After the polymers are dissolved, the cooling process of the boiler is terminated and other formulation contents are mixed by incorporating them into the system. After filling, packaging is made.
- aerosols are to be made, aluminum containers and bagged valve systems are filled under pressure and ventiles are installed. After the preparation of the gel formulation, optimization and characterization are performed with quality control parameters. In the next step, packaging selection is made for effective spraying. Shelf life calculation is carried out with stability.
- the inventive gel formulation in question is prepared as a solution and filled into spray bottles with trigger head, where spraying will be effective.
- the gel formulation in question When the gel formulation in question is pulverized, it should be a head that easily sprays its viscosity, which has not yet increased.
- the large pulvarization during spraying is important for its easy spread to the pulverized surface.
- the diameter of the spray's elevation pipe is slightly wider than normal spray pipes, allowing for a higher amount of product. Since there is no propellant, it is valuable for the monitoring and standardization of applications that the spray head of the ventil system is sprayed with a gun type when the liquid is fluid and does a single dosing and pulvarizes the same amount each time.
- the inventive gel formulation can also be applied as a propellant aerosol.
- the gas that does not come into contact with the product is filled into the container for pushing purposes only in the bag system called bag in valve.
- An effective spray is ensured as long as the aerosol activator is pressed.
- the trigger system is more convenient for laboratory studies and small quantities.
- the inventive gel formulation is suitable for industry with its use as a product in places where medical devices and medicines are produced. Mass production is possible. It must be sterile as it will be applied to burnt and injured tissue surfaces. Gamma sterilization can be applied if there is no sterilization at the production site.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Mycology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Microbiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Dermatology (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Preparation (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to the herbal and thermoreversible gel formulation (thermojel) that calms the burnt skin and accelerates its healing, and the method of production of the gel formulation in question.
Description
Thermoreversible gel formulation with herbal active materials in order to calm and accelarate the healing of burnt skin
Field of the Invention
The present invention relates to thermoreversible gel formulation with herbal active materials to calm and accelerate the healing of burnt skin and production method.
State of the Art
Burns are graded according to the severity of the traumas in the relevant technical field. In the case of sunburn known as first-degree burn, said burn is soothed by applying a product to the skin according to the aforementioned grading. However, it is difficult to apply the same by contact since the skin sensitivity increases in second and third degree burns. In case of application by contact, it is painful to patient and the comfort in applications is low. Moisturizing creams, ointments and gels are applied for sunburns and first degree burns.
Anesthetic agents, silver-containing creams, antimicrobial ointments and antiseptic effective solutions are used in second-degree burns and traumas. Applications are made to calm the region since the upper layer of the skin is burned. The burn area is deep and wide in griping and severely traumatized third-degree burns. Tissue loss is high and the risk of infection is high. The wounds of these patients are dressed under anesthesia. Debridement treatments are applied in order to accelerate tissue healing. Antiseptic solutions, dressings and antimicrobial ointments are applied. Necrotic tissues are cleaned and blood circulation of the tissues is supported. In particular, burns and dryness of the skin are experienced in cancer patients who have undergone radiation therapy. This region requires moistening and calming. In more serious cases, applications are required to accelerate tissue healing, prevent infection, and provide moisturizing in the skin integrity lost by applying anesthesia. In this case, pain may continue even under anesthesia.
In brief, the most important technical problem encountered frequently in the technical field is sensitivity in the inflammatory region in burn applications. Applications made by contacting obstruct patient compliance. According to the burn severity, it may be necessary to use consecutive products such as moisturizer, soothing and anti-infection products. In this case; there is a case of exposure to more than one drug. Wound healing process and scarring is also an important problem. The healing process and performance vary according to the condition of trauma and the condition of the case, the skill of the medical personnel who will evaluate the burn treatment and the medical supplies available. Patients who are treated with rays and have burns on their skin try to remove dermatitis and redness on the skin by using expensive products.
In this technical field, numerous alternative methods and studies have been tried as a solution to burn and wound applications. The documents identified in the patent and literature research on the known status of the technique are summarized below.
TR2017/22907 application numbered patent application, In the treatment of wounds caused by the burn, in the elimination of previously burned scars, and also to help remove calluses found in the body, a drug that acts as an antibiotic, contains the extract of the mentha piperita (mint) plant with antiseptic properties, arnebia euchroma plant extract, turpentine oil, egg yolk, castor oil and wax.
The patent application numbered TR2021/009075 relates to an ointment developed to provide treatment for two, three and four degree burns and to speed up the healing process. In the application, it is stated that the ointment in question contains fish oil and Vaseline.
TR2019/03364 application numbered patent application, for use against heat, electricity, chemicals and/or flame-induced skin destruction, it relates to a topically viable pharmaceutical composition containing olive oil (olea europa fruit oil and /or olive oil), egg oil (ovum oil), wheat oil (triticium vulgrai oil), retinyl palmitate (vitamin A), alpha tocoferol (vitamin E).
A product that consists of natural ingredients, used to have smooth skin that eliminates all kinds of burns on the skin and completely eliminates the pain and aesthetic
problems caused by the burn is disclosed in the patent application with application number TR 2017/00569.
Publication CN101856366 A Chinese patent application describes a burn cream containing 500 -1000 g of albolen, 20 - 30 g of borax, 1 - 4 g of borneol and 1 - 4 g of phenol according to its weight ratio. The document states that the aforementioned burn cream, compared to the previous technique, has the effects of relieving pain, promoting tissue, reducing inflammation and performing antibiotics, reducing scar hyperplasia and preventing the wound surface from becoming infected.
The Chinese patent application with publication number CN103610869 A relates to a burn cream containing safflower, sanguisorba officinalis, cacumen biotae, pseudoginseng, resina draconis and chrysanthemum indicum.
As a result due to the abovementioned disadvantages and the insufficiency of the current solutions regarding the subject matter, a development is required to be made in the relevant technical field.
Brief Description of the Invention
The current invention relates to the herbal and thermoreversible gel formulation (thermojel) and the production method of the gel formulation in question, which meets the aforementioned requirements, eliminates all disadvantages and brings some additional advantages, allows the burned skin to calm down and accelerates its healing.
The invention is inspired by current situations and aims to solve the above-mentioned negativity.
The main aim of the invention is; to obtain a gel formulation that provides innovation to the technical field with the application of both herbal and thermoreversible gels. In the invention, herbal extracts that provide calming and accelerate healing in accordance with the sensitivity of the burn area are used. At the same time, one of the important characterizing aspects of the invention is sprayable liquid gels, gelling with body temperature without any additional contact and application to the burnt area. Sprayed
and squeezed, the final product acts as a support for moisturizing, soothing and healing of the skin by clinging to living surfaces by gelling with body temperature.
The structural and characteristic features of the present invention will be understood clearly by the following detailed description and therefore the evaluation shall be made by taking the detailed description into consideration.
Detailed Description of the Invention
In this detailed description, the preferred embodiments of the inventive gel formulation are described by means of examples only for clarifying the subject matter.
The invention concerns the herbal and thermoreversible gel formulation (thermojel) that calms the burnt skin and accelerates its healing, and the production method of the gel formulation in question. The gel formulation in question, basically, contains herbal content, polymer and excipients. The components contained in the gel formulation in question and the preferred and available percentage usage rates of these components are given in the table below.
St. John's Wort extract is obtained from the whole or cut, dried flowering tops of Hypericum perforatum L. harvested during the flowering period. St. John's Wort (SJW), known botanically as Hypericum perforatum, is a spreading, leafy herb that grows in open, disturbed areas in most of the world's temperate regions. The use of this species as a herbal medicine to treat various internal and external ailments dates back to the
time of the ancient Greeks. H. perforatum consists of freely branching bush plants, typically 40 to 80 cm in height. Stems and branches are intensively covered with rectangular, smooth-edged leaves 1 to 3 cm long and 0.3 to 1.0 cm wide. It contains hypericin and hyperforin. It is used externally in the healing of wounds and burns. They cause changes in dopamine and serotonin levels in the body when taken internally.
Olive leaf extract is obtained from Olea europaea, a plant belonging to the Oleaceae family. The olive tree is an evergreen tree that grows to a height of about 6 - 9 meters. It is endemic to the entire Mediterranean region, up to Southern European countries and Iran and beyond the Caucasus. Leaves are 7.5 cm long, opposite narrow, in the form of lance or linear, entire margins are pointed, silvery-green (graygreen) above, lighter underside, has fine white, flake-like hairs. Leaves can be collected throughout the year. The main components of olive leaves are oleuropein, ligstroside, I methyloleuropein and oleoside, and flavonoids (apigenin, kaempferol, luteolin, chrysoeriol) and phenolic compounds (caffeic acid, tyrosol, hydroxytrozole). In addition to antioxidant activity, it shows antiviral effect. It increases blood circulation.
There are 35 types of thyme in our country. The species we will use is Thymus vulgaris that belongs to the Lamiaceae family. It is native to the Mediterranean. It grows up to 15 - 30 cm high and 40 cm wide. It is a bushy, evergreen shrub-type plant with purple or pink flowers and highly aromatic gray-green leaves. While it contains high levels of thymol, p-cymene and y-terpinene, it also contains carvacrol, borneol, 1 ,8-cineole, q- cimene, linalool, a-pinene, camphor and myrcene. It has a protective and germicidal effect against bacteria and fungi.
In the production method of the gel formulation in question, the polymer is soluble in deionized water at +4 tC. The temperature of the water can be brought to +4 ‘C by cooling the water that is making the speed in the boiler walls industrially. The alternative way is to heat it. However, working in the cold positively affects stability, as the substances that will provide treatment support to the content will be disturbed by temperature. Another way is to break down the polymers with the help of powerful homogenizers. In the process, pilot trials continue through which method is more suitable for industrial production. After the polymers are dissolved, the cooling process of the boiler is terminated and other formulation contents are mixed by incorporating them into the system. After filling, packaging is made. If aerosols are to be made,
aluminum containers and bagged valve systems are filled under pressure and ventiles are installed. After the preparation of the gel formulation, optimization and characterization are performed with quality control parameters. In the next step, packaging selection is made for effective spraying. Shelf life calculation is carried out with stability.
The inventive gel formulation in question is prepared as a solution and filled into spray bottles with trigger head, where spraying will be effective. When the gel formulation in question is pulverized, it should be a head that easily sprays its viscosity, which has not yet increased. The large pulvarization during spraying is important for its easy spread to the pulverized surface. The diameter of the spray's elevation pipe is slightly wider than normal spray pipes, allowing for a higher amount of product. Since there is no propellant, it is valuable for the monitoring and standardization of applications that the spray head of the ventil system is sprayed with a gun type when the liquid is fluid and does a single dosing and pulvarizes the same amount each time.
The inventive gel formulation can also be applied as a propellant aerosol. The gas that does not come into contact with the product is filled into the container for pushing purposes only in the bag system called bag in valve. An effective spray is ensured as long as the aerosol activator is pressed. The trigger system is more convenient for laboratory studies and small quantities.
The inventive gel formulation is suitable for industry with its use as a product in places where medical devices and medicines are produced. Mass production is possible. It must be sterile as it will be applied to burnt and injured tissue surfaces. Gamma sterilization can be applied if there is no sterilization at the production site.
Claims
CLAIMS 1. A herbal and thermoreversible gel formulation that allows the burnt skin to calm and accelerate its healing to be applied by spraying, characterized by comprising; St. John's Wort extract, olive leaf extract, thyme extract, polymer and excipient. 2. The gel formulation according to claim 1 , characterized by comprising; St. John's Wort extract, olive leaf extract, thyme extract, Poloxamer 407, Polyethylene glycol 1500, pH regulator, preservative and deionized water. 3. The gel formulation according to claim 2, characterized by comprising; St. John's Wort extract in the range of 0.1 - 5% by weight, Olive leaf extract in the range of 0.1 - 5%, thyme extract in the range of 0.1 - 5%, Poloxamer 407 in the range of 0.1 - 20%, Polyethylene glycol 1500, pH regulator in the range of 0.1 -
5%, preservative in the range of 0.01 - 1% and deionized water in the range of 49 - 99.39%.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/TR2021/051539 WO2023128884A1 (en) | 2021-12-28 | 2021-12-28 | Thermoreversible gel formulation with herbal active materials in order to calm and accelarate the healing of burnt skin |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/TR2021/051539 WO2023128884A1 (en) | 2021-12-28 | 2021-12-28 | Thermoreversible gel formulation with herbal active materials in order to calm and accelarate the healing of burnt skin |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2023128884A1 true WO2023128884A1 (en) | 2023-07-06 |
Family
ID=87000096
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/TR2021/051539 WO2023128884A1 (en) | 2021-12-28 | 2021-12-28 | Thermoreversible gel formulation with herbal active materials in order to calm and accelarate the healing of burnt skin |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2023128884A1 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN117959479A (en) * | 2024-02-01 | 2024-05-03 | 中国中医科学院中医基础理论研究所 | Preparation method of three-dimensional traditional Chinese medicine dressing for treating pressure sores and three-dimensional traditional Chinese medicine dressing prepared by preparation method |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GEP19981089B (en) * | 1996-05-10 | 1998-06-09 | Nino Shikhashvili | Green Ointment |
EP2829276A1 (en) * | 2012-03-22 | 2015-01-28 | Garcia Gilabert, Juan Miguel | Composition for preventing and/or treating dermatosis and method for obtaining same |
CN108355130A (en) * | 2018-05-22 | 2018-08-03 | 界首市菁华科技信息咨询服务有限公司 | It is a kind of to treat psoriasic temperature sensitive type collagen composite antiphlogistic gel spray and preparation method thereof |
-
2021
- 2021-12-28 WO PCT/TR2021/051539 patent/WO2023128884A1/en active Application Filing
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GEP19981089B (en) * | 1996-05-10 | 1998-06-09 | Nino Shikhashvili | Green Ointment |
EP2829276A1 (en) * | 2012-03-22 | 2015-01-28 | Garcia Gilabert, Juan Miguel | Composition for preventing and/or treating dermatosis and method for obtaining same |
CN108355130A (en) * | 2018-05-22 | 2018-08-03 | 界首市菁华科技信息咨询服务有限公司 | It is a kind of to treat psoriasic temperature sensitive type collagen composite antiphlogistic gel spray and preparation method thereof |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN117959479A (en) * | 2024-02-01 | 2024-05-03 | 中国中医科学院中医基础理论研究所 | Preparation method of three-dimensional traditional Chinese medicine dressing for treating pressure sores and three-dimensional traditional Chinese medicine dressing prepared by preparation method |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US4318906A (en) | Medicinal composition for external use for treating wounds | |
Raina et al. | Medicinal plants and their role in wound healing | |
US12171774B2 (en) | Topical analgesic | |
Artem Ataide et al. | Natural actives for wound healing: A review | |
CN104688810A (en) | Antibacterial composition based on natural plant raw material and application of antibacterial composition | |
CN104688811A (en) | Acne removal composition based on natural plant raw materials and application thereof | |
CN101780149B (en) | Compound wintersweet leaf extract, preparation method and applications thereof | |
Li et al. | Evaluation of effectiveness in a novel wound healing ointment-crocodile oil burn ointment | |
US20230338452A1 (en) | Ointment-based skin wound treatment method | |
CN104887593A (en) | A pure plant natural mosquito repellent | |
CN104434740A (en) | Traditional Chinese medicine gel for removing acnes and preparation method of traditional Chinese medicine gel | |
WO2023128884A1 (en) | Thermoreversible gel formulation with herbal active materials in order to calm and accelarate the healing of burnt skin | |
Ande et al. | Potential herbal essential oils: Are they super natural skin protector | |
KR102345209B1 (en) | Sanitizer composition has excellent anti-viral effect, sterilization effect and skin moisturizing effect | |
Kreidel et al. | Introduction to essential oils and essential oil processing | |
CN112105372A (en) | Base composition for the production of bioactive agents | |
Ullah et al. | Medicinal benefits of lemon balm (Melissa officinalis) for human health | |
CN108339073A (en) | A kind of extracts of Chinese herbal medicine and preparation method thereof for treating skin discomfort | |
EP1357926B1 (en) | Local use of ethereal oils | |
CN115518127B (en) | Antibacterial, anti-inflammatory, swelling, antipruritic cream and preparation method thereof | |
CN104127606A (en) | Externally-applied wound surface repairing ointment prescription and preparation method thereof | |
Ande et al. | Medicinal herbs: Why to include in diabetic foot ulcer therapy? A review | |
ES2811317T3 (en) | Therapeutic product for the treatment of pressure ulcers through the creation of a healing scab when spraying | |
RU2139078C1 (en) | Composition for treatment of patients with dermal sicknesses | |
CN113813308A (en) | Medicine for treating burn and scald and preparation method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 21970132 Country of ref document: EP Kind code of ref document: A1 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 21970132 Country of ref document: EP Kind code of ref document: A1 |